Related Experiment Videos
Sex hormones, the menopause and urinary problems
1Department of Urogynaecology, King's College Hospital, London, UK.
Summary
Estrogen therapy shows promise for preventing urinary tract infections and improving quality of life in postmenopausal women. Its effectiveness for urinary incontinence requires further research, potentially as an adjunct treatment.
Area of Science:
- Gynecology
- Urology
- Gerontology
Background:
- Limited placebo-controlled studies exist for estrogen therapy in urinary incontinence.
- Heterogeneous study protocols complicate treatment recommendations.
- Optimal estrogen type, dose, and administration route remain undetermined.
Purpose of the Study:
- To review the efficacy of estrogen therapy for menopausal urinary disorders.
- To identify the role of estrogen in treating urinary incontinence and related symptoms.
- To explore estrogen's potential as an adjunct therapy.
Main Methods:
- Review of existing placebo-controlled studies.
- Analysis of subjective and objective parameters for efficacy.
- Evaluation of different estrogen formulations and administration routes.
Main Results:
- Estrogen therapy effectively prevents/treats recurrent urinary tract infections.
- Systemic estrogen alleviates urgency, frequency, and nocturia.
- Topical estrogen manages atrophic vaginitis with minimal side effects.
Conclusions:
- Estrogen therapy is beneficial for UTIs and atrophic vaginitis.
- Evidence for treating urinary incontinence alone is inconclusive; may aid stress incontinence with alpha-adrenergic agonists.
- Estrogen improves quality of life and may serve as an adjunct treatment for postmenopausal urinary disorders.